Gopalan Narendran

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn et al. · The Lancet · 2022 · 145 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +11

Mycobacterial Antigen Driven Activation of CD14++CD16− Monocytes Is a Predictor of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome

Bruno B. Andrade, Amrit Singh, Gopalan Narendran et al. · PLoS Pathogens · 2014 · 116 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Impact of HIV Infection on the Recurrence of Tuberculosis in South India

Sujatha Narayanan, Soumya Swaminathan, Philip Supply et al. · The Journal of Infectious Diseases · 2010 · 113 citations · Full text

Public Health, Immunology, Infectious Diseases +17

Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) in HIV Patients with Culture Confirmed Pulmonary Tuberculosis in India and the Potential Role of IL-6 in Prediction

Gopalan Narendran, Bruno B. Andrade, Brian Porter et al. · PLoS ONE · 2013 · 100 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Efficacy of a 6-month versus 9-month Intermittent Treatment Regimen in HIV-infected Patients with Tuberculosis: A Randomized Clinical Trial

Soumya Swaminathan, Gopalan Narendran, Venkatesan Perumal et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 87 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14